HomeKZR • NASDAQ
add
Kezar Life Sciences Inc
Previous close
$4.29
Day range
$4.16 - $4.45
Year range
$3.53 - $8.95
Market cap
31.71M USD
Avg Volume
44.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.02M | -10.48% |
Net income | -13.70M | 36.40% |
Net profit margin | — | — |
Earnings per share | -1.87 | 32.11% |
EBITDA | -14.36M | 33.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 100.85M | -38.57% |
Total assets | 109.12M | -39.35% |
Total liabilities | 17.34M | -40.70% |
Total equity | 91.79M | — |
Shares outstanding | 7.32M | — |
Price to book | 0.34 | — |
Return on assets | -31.14% | — |
Return on capital | -33.02% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -13.70M | 36.40% |
Cash from operations | -12.80M | 24.87% |
Cash from investing | 11.40M | -6.70% |
Cash from financing | -1.27M | -2,366.07% |
Net change in cash | -2.64M | 44.60% |
Free cash flow | -7.32M | 11.21% |
About
Founded
2015
Headquarters
Website
Employees
55
